Following staff and student feedback, D2L Brightspace was selected to support the University’s ambition for digital innovation and equitable student success LONDON, UK – 8th June, 2022 – D2L, a global learning technology company transforming the way the world learns, today announced that the University of Cape Town (UCT) has partnered with reseller Visions Consulting… Read More »
Gene-editing technology CRISPR reached a major milestone this past weekend, completing its first systemic delivery as a medicine to a human body. CRISPR, or clustered regularly interspaced short palindromic repeats, effectively cuts genomes and slices DNA to treat genetic diseases. The latest breakthrough, the result of a trial between biotech company Regeneron and Boston-based startup… Read More »
Interest in psychedelics as therapeutics has risen in recent years, spurred by studies that have found that the once-maligned drugs used in conjunction with therapy can help in the treatment of psychiatric patients. Amid a rush to commercialize a suite of newly developed products, Massachusetts General Hospital (MGH) has begun a new Center for the… Read More »
Aduhelm by Biogen Source: Biogen The FDA’s approval of Biogen‘s Alzheimer’s drug Aduhelm was a landmark moment in the life of Dr. Paul Aisen. The director of the Alzheimer’s Therapeutic Research Institute at USC has spent the past three decades focused on treating the neurodegenerative disease, and in recent years helped shepherd this particular drug… Read More »
The pandemic has become a sort of forcing function on all aspects of daily living, include health care. Deloitte’s latest wave of health care consumer market research updates the COVID-19 impacts on the U.S. health care landscape and asks the question in the study report’s title: “Are consumers already living the future of health?” For… Read More »